Added value of risk calculators to mpMRI in the diagnosis of prostate cancer

Added value of risk calculators to mpMRI in the diagnosis of prostate cancer

Bibliographic Details
Main Authors:	J.R. Gonçalves Correia, M. Madanelo, B. Teixeira, G. Mendes, A. Fraga, F. Teves, M. Silva-Ramos
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320337642

Similar Items

The combined value of mpUS and mpMRI-TRUS fusion for the diagnosis of clinically significant prostate cancer
by: Xin Zhang, et al.
Published: (2022-10-01)

Differential diagnosis of uncommon prostate diseases: combining mpMRI and clinical information
by: Chao Han, et al.
Published: (2021-06-01)

Mischievous malakoplakia: A potential pitfall of mpMRI of the prostate?
by: Michael E. Rezaee, et al.
Published: (2020-09-01)

Clash of the calculators: External validation of prostate cancer risk calculators in men undergoing mpMRI and transperineal biopsy
by: G. Wei, et al.
Published: (2021-05-01)

Which prostate cancers are overlooked by mpMRI? An analysis from PROMIS
by: J. Norris, et al.
Published: (2020-07-01)

Comparison between biparametric prostate MRI (bpMRI) and multiparametric MRI (mpMRI) in the detection of prostate cancer
by: A. Iseppi, et al.
Published: (2020-01-01)

Accuracy of mpMRI in detecting lesion location in prostate cancer-inital experience
by: M. Parameswaran, et al.
Published: (2020-11-01)

Analisys of contralateral prostatic cancer odds in patients with monolateral lesions at mpMRI
by: A. Iseppi, et al.
Published: (2020-01-01)

Analysis of the cause of missed diagnosis in mpMRI/TRUS fusion-guided targeted prostate biopsy
by: Fan Zhang, et al.
Published: (2022-05-01)

Applications of Artificial Intelligence to Prostate Multiparametric MRI (mpMRI): Current and Emerging Trends
by: Michelle D. Bardis, et al.
Published: (2020-05-01)

bpMRI and mpMRI for detecting prostate cancer: A retrospective cohort study
by: Yongsheng Pan, et al.
Published: (2023-01-01)

Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI
by: Miriam Campistol, et al.
Published: (2022-05-01)

Targeted prostate biopsy: 68Ga-PSMA PET/CT vs. mpMRI in the diagnosis of prostate cancer
by: Pietro Pepe, et al.
Published: (2022-09-01)

Comparing Micro-Ultrasound to mpMRI in Detecting Clinically Significant Prostate Cancer
by: Christian Pavlovich, et al.
Published: (2022-02-01)

Indeterminate mpMRI lesions: Evaluating the optimal PSA density threshold for prostate biopsy
by: D.T. Reddy, et al.
Published: (2020-07-01)

Radiomic analysis of T2 and ADC mpMRI images in the diagnosis of clinical significant prostate cancer: An early experience
by: F. Prata, et al.
Published: (2020-07-01)

Radiomic analysis of T2 and ADC mpMRI images in the diagnosis of clinical significant prostate cancer: An early experience
by: F. Prata, et al.
Published: (2020-10-01)

Quantib Prostate Compared to an Expert Radiologist for the Diagnosis of Prostate Cancer on mpMRI: A Single-Center Preliminary Study
by: Eliodoro Faiella, et al.
Published: (2022-08-01)

Prostate “Mapeo” for cancer diagnosis: The Madrid protocol. Transperineal prostate biopsies combining Micro-ultrasound and mpMRI fusion biopsy.
by: M.E. Rodríguez Socarrás, et al.
Published: (2020-01-01)

Prostate mapping for cancer diagnosis: The Madrid protocol. Transperineal prostate biopsies combining micro-ultrasound and mpMRI fusion biopsy
by: M.E. Rodríguez Socarrás, et al.
Published: (2020-07-01)

Diagnostic performance of micro-ultrasound prostate biopsies in patients undergoing mpMRI-fusion biopsies
by: D. Maffei, et al.
Published: (2020-07-01)

Micro-ultrasound guided prostate biopsies for clinically significant prostate cancer diagnosis in a cohort of biopsy-naive patients with mpMRI
by: D. Maffei, et al.
Published: (2020-11-01)

Which men should undergo non-targeted systematic sampling in an mpMRI-targeted pathway – an analysis from 1,719 pre-biopsy mpMRI cases?
by: M.J. Connor, et al.
Published: (2020-07-01)

Dynamic Contrast-Enhanced Study in the mpMRI of the Prostate—Unnecessary or Underutilised? A Narrative Review
by: Silva Guljaš, et al.
Published: (2023-11-01)

The role of mpMRI in qualification of patients with ISUP 1 prostate cancer on biopsy to radical prostatectomy
by: Łukasz Nyk, et al.
Published: (2021-05-01)

Automated Diagnosis of Prostate Cancer Using mpMRI Images: A Deep Learning Approach for Clinical Decision Support
by: Anil B. Gavade, et al.
Published: (2023-07-01)

Prostate mpMRI and MRI-Targeted Biopsy: State-of-the-art Protocol + PI-RADS v2.1
by: Pieter De Visschere, et al.
Published: (2019-11-01)

mpMRI-visible prostate cancer is enriched with genomic hallmarks of poor prognosis: A bioinformatic analysis
by: J. Norris, et al.
Published: (2020-07-01)

Elucidating the need for prostate cancer risk calculators in conjunction with mpMRI in initial risk assessment before prostate biopsy at a tertiary prostate cancer center
by: Philipp Krausewitz, et al.
Published: (2024-03-01)

Transrectal Ultrasound in Prostate Cancer: Current Utilization, Integration with mpMRI, HIFU and Other Emerging Applications
by: Panzone J, et al.
Published: (2022-03-01)

Multiparametric magnetic resonance imaging (mpMRI): Which variable better predicts extracapsular extension of prostate cancer?
by: M.C. Sighinolfi, et al.
Published: (2020-01-01)

Correlation between Gleason score and PIRADS score on mpMRI –initial experience
by: M. Parameswaran, et al.
Published: (2020-11-01)

Negative mpMRI Rules Out Extra-Prostatic Extension in Prostate Cancer before Robot-Assisted Radical Prostatectomy
by: Eoin Dinneen, et al.
Published: (2022-04-01)

Utility of mpMRI/transrectal US fusion confirmatory biopsy in men with a previous diagnosis of prostate cancer amenable to active surveillance
by: G. Zecchini, et al.
Published: (2020-07-01)

Exploring the efficacy of multi-flavored feature extraction with radiomics and deep features for prostate cancer grading on mpMRI
by: Hasan Khanfari, et al.
Published: (2023-11-01)

Microvascular proliferation is associated with high tumour blood flow by mpMRI and disease progression in primary prostate cancer
by: Astrid Børretzen, et al.
Published: (2023-10-01)

Developing a predictive model for clinically significant prostate cancer by combining age, PSA density, and mpMRI
by: Zengni Ma, et al.
Published: (2023-03-01)

The RAPID risk model: A novel risk score to predict significant prostate cancer in men with an mpMRI lesion
by: D. Eldred-Evans, et al.
Published: (2020-07-01)

Performance of prostate health index and PSA density in a diverse biopsy‐naïve cohort with mpMRI for detecting significant prostate cancer
by: Samuel Carbunaru, et al.
Published: (2021-11-01)

Development and validation of a predictive model based on clinical and MpMRI findings to reduce additional systematic prostate biopsy
by: Xueqing Cheng, et al.
Published: (2024-01-01)